Company research / AURX
Nuo Therapeutics, Inc. (AURX)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Nuo Therapeutics, Inc. reported revenue of $3.31M. Revenue grew 142.7% from the prior annual period.
Key ratios (year ended 2025-12-31)
66.9%
Gross margin
-76.0%
Operating margin
-75.8%
Net margin
142.7%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.